Shimadzu Corporation (SHMZF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Shimadzu Corporation (SHMZF) trades at $24.49 with AI Score 51/100 (Grade B). Shimadzu Corporation is a global manufacturer of analytical and measuring instruments, medical systems, industrial machinery, and aircraft equipment. Market cap: $7.08B, Sector: Technology.
Price live · AI analysis from Jun 15, 2026Analyst Coverage for SHMZF: SHMZF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates SHMZF against Technology peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
SHMZF: 4/6 perspectives are bullish. Dominant signal: Izzy Englander bullish.
How is this calculated? →Shimadzu Corporation (SHMZF) Technology Profile & Competitive Position
Shimadzu Corporation, established in 1875, is a global technology leader specializing in analytical and measuring instruments, medical systems, industrial machinery, and aircraft equipment. Headquartered in Kyoto, Japan, the company delivers a diverse portfolio of advanced solutions across multiple high-tech sectors, serving a worldwide customer base with precision engineering.
What Is the Investment Thesis for SHMZF?
Shimadzu Corporation presents a compelling profile driven by its diversified portfolio, strong profitability, and global market presence. With a market capitalization of $7.08B, the company benefits from its extensive reach across analytical instruments, medical systems, industrial machinery, and aircraft equipment. Its financial health is underscored by a gross margin of 44.6% and a profit margin of 10.8%, indicating efficient operations and effective cost management. The P/E ratio of 19.7 suggests a reasonable valuation for a company with a stable business model and a Beta of 0.73, indicating lower volatility relative to the broader market. Growth catalysts include ongoing global demand for advanced analytical solutions in life sciences and environmental monitoring, the expansion of healthcare infrastructure driving medical system adoption, and continuous innovation in industrial and aerospace technologies. The company also offers a dividend yield of 1.84%, providing a return to shareholders. While exposed to global economic fluctuations and intense competition, Shimadzu's long history and diversified revenue streams provide a foundation for sustained performance.
Based on FMP financials and quantitative analysis
SHMZF Key Highlights
- Market Capitalization: $7.08 billion, reflecting its substantial presence in global technology markets and diversified operations.
- Profitability: A robust gross margin of 44.6% and a profit margin of 10.8% demonstrate efficient manufacturing and strong pricing power across its diverse product lines.
- Valuation: A P/E ratio of 19.7 suggests a reasonable valuation for a company with a stable, diversified business model and consistent earnings.
- Shareholder Returns: Offers a dividend yield of 1.84%, providing income to investors alongside potential capital appreciation from its established market position.
- Market Stability: A Beta of 0.73 indicates lower volatility compared to the broader market, appealing to investors seeking more stable equity exposure in the technology sector.
Who Are SHMZF's Competitors?
SHMZF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| MNBEF MINEBEA MITSUMI Inc. | $25.47 | -4.36% | $10.23B | 51 |
| OMRNF OMRON Corporation | $38.55 | +0.00% | $7.58B | 50 |
| FITGF FIT Hon Teng Limited | $0.79 | -5.14% | $5.62B | 49 |
| AACAY AAC Technologies Holdings Inc. | $5.13 | -6.22% | $5.93B | 46 |
| HROEY Hirose Electric Co.,Ltd. | $19.41 | +0.00% | $6.35B | 54 |
| MDA Macdonald Dettwiler & Associate | $42.11 | +3.34% | 6B | 66 |
| WATT Energous Corporation | $19.29 | -19.93% | $28.65M | 65 |
| SELX Selecta Biosciences, Inc. | $0.34 | +580.00% | $12.78M | 64 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are SHMZF's Key Strengths?
- Highly diversified product portfolio across analytical, medical, industrial, and aerospace sectors.
- Strong global presence and established distribution networks worldwide.
- Long history of innovation and a reputable brand built since 1875.
- Robust financial performance indicated by strong gross and profit margins.
- Significant investment in research and development, leading to advanced technological solutions.
What Are SHMZF's Weaknesses?
- Exposure to economic cycles across multiple diverse industries, which can lead to varied demand fluctuations.
- Potential for complex global supply chains, increasing vulnerability to disruptions and cost volatility.
- Reliance on highly specialized technical talent for R&D and manufacturing, posing recruitment and retention challenges.
- High capital expenditure requirements for R&D and manufacturing facilities to maintain technological leadership.
What Could Drive SHMZF Stock Higher?
- Global demand for advanced analytical instruments in life sciences and environmental monitoring, driving sales in a key segment.
- Expansion of healthcare infrastructure and adoption of advanced medical imaging technologies worldwide, boosting medical systems revenue.
- Continued investment in research and development leading to new product introductions and technological advancements across its diverse portfolio.
- Potential for strategic partnerships or acquisitions to expand market reach or integrate complementary technologies, enhancing competitive positioning.
What Are the Key Risks for SHMZF?
- Intense global competition across its diverse business segments, potentially impacting market share and pricing power in key markets.
- Fluctuations in global economic conditions, which could affect demand for industrial machinery and capital expenditure on analytical and medical systems.
- Rapid technological advancements requiring continuous and significant R&D investment to avoid obsolescence and maintain a competitive edge.
- Supply chain disruptions or increases in raw material costs, which could impact production schedules and profitability margins.
- Regulatory changes in the healthcare, environmental, or aerospace sectors that could impose new compliance costs or restrict market access for certain products.
What Are the Growth Opportunities for SHMZF?
- Growth opportunity 1: Expanding demand for advanced analytical instruments in life sciences and environmental monitoring. The global analytical instruments market is projected to see consistent growth, driven by increasing R&D spending in pharmaceuticals, biotechnology, and food safety, alongside stricter environmental regulations. Shimadzu's comprehensive portfolio, including gas and liquid chromatography, mass spectrometry, and molecular spectroscopy, positions it to capture a significant share of this expanding market. Its long-standing expertise provides a competitive advantage in delivering high-precision, reliable solutions to critical industries worldwide.
- Growth opportunity 2: Increasing global healthcare expenditure and the adoption of advanced medical imaging systems. With an aging global population and rising chronic disease prevalence, there is a sustained demand for sophisticated diagnostic and therapeutic medical systems. Shimadzu's offerings, such as angiography, fluoroscopy, and mobile X-ray systems, are crucial for modern healthcare infrastructure. The company can capitalize on this trend by continuously innovating its medical technology and expanding its presence in emerging markets with growing healthcare needs, ensuring long-term revenue streams.
- Growth opportunity 3: Rising demand for precision industrial machinery and vacuum technology, particularly in semiconductor and advanced materials manufacturing. The global push for miniaturization and high-performance materials requires advanced manufacturing processes supported by precision equipment like turbo molecular pumps, sputtering systems, and vacuum heat-treatment furnaces. Shimadzu's expertise in these areas positions it to benefit from capital expenditures in high-tech manufacturing sectors. The company's ability to provide reliable and high-performance industrial solutions offers a competitive edge in this specialized market.
- Growth opportunity 4: Continued growth in the global aerospace and defense sectors. As air travel recovers and defense spending remains robust globally, there is an ongoing demand for advanced and reliable aircraft equipment. Shimadzu's contributions, including electro-mechanical actuators, flight control systems, and landing gear systems, are integral to modern aircraft. The company can leverage its precision engineering capabilities and established relationships within the aerospace industry to secure new contracts and expand its market share, contributing to stable, long-term revenue growth.
- Growth opportunity 5: Leveraging continuous investment in research and development to penetrate new application areas and markets. Shimadzu's long history of innovation and strong R&D capabilities allow it to adapt its core technologies to emerging scientific and industrial challenges. This includes developing new solutions for materials science, advanced manufacturing, and personalized medicine. By maintaining a proactive R&D pipeline, Shimadzu can introduce novel products, enhance existing offerings, and explore untapped market segments, ensuring its competitive relevance and fostering future revenue streams.
What Opportunities Does SHMZF Have?
- Growth in emerging markets for healthcare infrastructure and industrial development.
- Technological advancements in AI and automation, enhancing product capabilities and operational efficiency.
- Strategic acquisitions or partnerships to expand market reach or integrate complementary technologies.
- Expansion into new application areas for existing technologies, such as advanced materials or personalized medicine.
- Increasing demand for environmental monitoring and sustainable solutions driving analytical instrument sales.
What Threats Does SHMZF Face?
- Intense global competition from specialized players in each of its diverse business segments.
- Rapid technological obsolescence requiring continuous and significant R&D investment.
- Global economic downturns or geopolitical instability impacting capital expenditure and consumer demand.
- Regulatory changes in healthcare, environmental, and aerospace sectors affecting product development and market access.
- Currency fluctuations impacting international sales and profitability.
What Are SHMZF's Competitive Advantages?
- Extensive patent portfolio and deep R&D capabilities in precision instrumentation, advanced materials, and complex systems, fostering continuous innovation.
- Global distribution and service network supporting a diverse range of product lines across analytical, medical, industrial, and aerospace sectors, ensuring broad market access.
- Long-standing brand reputation and trust built since 1875 for quality, reliability, and precision in high-tech equipment, creating significant customer loyalty.
- Diversified product portfolio across multiple high-tech segments, which mitigates risks associated with reliance on any single market or industry downturn.
- Specialized technical expertise and accumulated knowledge in complex engineering and scientific fields, making it difficult for new entrants to replicate their offerings.
What Does SHMZF Do?
Shimadzu Corporation, founded in 1875 and headquartered in Kyoto, Japan, has evolved into a globally recognized manufacturer of advanced technological products across several critical sectors. The company's extensive portfolio encompasses analytical and measuring instruments, medical systems, industrial machinery, and aircraft equipment, serving a worldwide customer base. In the analytical instruments segment, Shimadzu offers a comprehensive suite of products including gas and liquid chromatography, mass spectrometry, molecular spectroscopy, elemental analysis, and life science lab instruments. These instruments are vital for research, quality control, and environmental monitoring across various industries. Its medical systems division provides essential healthcare technology, such as angiography, fluoroscopy, mobile C-arm, radiography, mobile X-ray systems, and fluorescence imaging products, supporting advanced diagnostics and treatment. Beyond these, Shimadzu is a significant player in industrial machinery, manufacturing turbo molecular pumps, helium leak detectors, sputtering systems, vacuum heat-treatment furnaces, and precision gear pumps. The company also contributes to the aerospace sector by supplying critical aircraft equipment, including electro-mechanical actuators, flight control systems, and landing gear systems. With a long history of innovation and a commitment to precision engineering, Shimadzu Corporation maintains a strong market position by continuously developing high-performance solutions that address complex scientific, medical, and industrial challenges globally.
What Products and Services Does SHMZF Offer?
- Manufacture and sell analytical instruments like gas and liquid chromatographs, mass spectrometers, and molecular spectroscopes for scientific research and quality control.
- Develop and provide medical imaging systems, including angiography, fluoroscopy, and mobile X-ray units for advanced healthcare diagnostics.
- Produce industrial machinery such as turbo molecular pumps, helium leak detectors, and vacuum heat-treatment furnaces for manufacturing and research applications.
- Offer specialized hydraulic equipment, including hydraulic gear pumps, power packages, and multi control valves for various industrial applications.
- Supply critical aircraft equipment, such as electro-mechanical actuators, flight control systems, and landing gear systems for the aerospace industry.
- Provide data management and software solutions that complement their analytical and measuring instruments, enhancing data interpretation and workflow efficiency.
- Engage in materials testing and non-destructive testing solutions for quality assurance and integrity assessment across diverse industries.
- Develop life science lab instruments, including total organic carbon analyzers and particle size analyzers, for biological and chemical analysis.
How Does SHMZF Make Money?
- Selling a diverse range of analytical and measuring instruments to research institutions, pharmaceutical companies, environmental agencies, and industrial clients globally.
- Generating revenue from the sale and installation of medical systems to hospitals, clinics, and other healthcare providers worldwide.
- Profiting from the manufacturing and distribution of industrial machinery and hydraulic equipment for various manufacturing sectors, including semiconductor and automotive.
- Earning from the supply of specialized aircraft equipment to aerospace manufacturers and defense contractors, contributing to critical aviation infrastructure.
- Providing after-sales service, maintenance contracts, and consumables for their extensive product portfolio, ensuring ongoing customer support and recurring revenue.
What Industry Does SHMZF Operate In?
Shimadzu Corporation operates within the highly specialized and competitive Technology sector, specifically in Hardware, Equipment & Parts. The company's unique position stems from its diversification across analytical instruments, medical systems, industrial machinery, and aircraft equipment. This strategy allows Shimadzu to tap into multiple growth trends, including the increasing demand for precision diagnostics in healthcare, advanced research and development in life sciences, and automation in industrial processes. The competitive landscape is fragmented, with specialized players in each segment, but Shimadzu's comprehensive offerings and long-standing reputation for quality provide a distinct advantage. Market trends indicate sustained growth in areas requiring high-precision measurement and analysis, driven by technological advancements and regulatory requirements. Shimadzu's ability to innovate and adapt its core technologies across these diverse applications positions it as a key supplier in critical global industries.
Who Are SHMZF's Key Customers?
- Research institutions, universities, and government laboratories conducting scientific investigations.
- Pharmaceutical, biotechnology, and chemical companies requiring precision analytical instruments for R&D and quality control.
- Hospitals, clinics, and diagnostic centers utilizing advanced medical imaging and diagnostic systems.
- Industrial manufacturers across various sectors, including automotive, electronics, and materials processing, needing specialized machinery and hydraulic equipment.
- Aerospace and defense contractors procuring high-precision aircraft components and systems.
Company Profile
Shimadzu Corporation operates in the Hardware, Equipment & Parts industry within the Technology sector. It is headquartered in Kyoto, JP. The company is led by CEO Yasunori Yamamoto. SHMZF has traded publicly since 2014.
F-Score 6/9Financial Health
Shimadzu Corporation's Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 6.47 places it in the safe zone, indicating low near-term bankruptcy risk.
ROE 12%Key Financial Metrics
Return on equity for Shimadzu Corporation stands at 11.5%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 8.2%, showing how much profit it generates from its asset base. SHMZF trades at a trailing price-to-earnings ratio of 19.75, below the Technology sector average of ~38x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 3.31 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 5.1%, the inverse of the P/E and a quick read on earnings relative to price.
SHMZF Valuation & Market Position
With a $7.08B market cap, Shimadzu Corporation sits in the mid-cap segment of the market. Relative to its peer group, SHMZF's quantitative score of 51/100 is roughly in line with the peer average of 50/100.
FY2026 estForward Outlook
Wall Street analysts project Shimadzu Corporation revenue of about $558.79B for fiscal 2026, with EPS near $189.10. The estimate reflects 12 contributing analysts.
SHMZF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2026
Bull Case vs Bear Case
Bull Case
- Highly diversified product portfolio across analytical, medical, industrial, and aerospace sectors.
- Strong global presence and established distribution networks worldwide.
- Long history of innovation and a reputable brand built since 1875.
- Robust financial performance indicated by strong gross and profit margins.
Bear Case
- Exposure to economic cycles across multiple diverse industries, which can lead to varied demand fluctuations.
- Potential for complex global supply chains, increasing vulnerability to disruptions and cost volatility.
- Reliance on highly specialized technical talent for R&D and manufacturing, posing recruitment and retention challenges.
- High capital expenditure requirements for R&D and manufacturing facilities to maintain technological leadership.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
SHMZF Latest News
-
Shimadzu Medical Systems USA announces the release of the FLUOROspeed X1 edition ST
Yahoo! Finance: SHMZF News · Jun 17, 2026
SHMZF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for SHMZF.
Price Targets
Wall Street price target analysis for SHMZF.
SHMZF MoonshotScore
What does this score mean?
The MoonshotScore rates SHMZF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry Hardware, Equipment & PartsLeadership: Yasunori Yamamoto
CEO
Unknown
Track Record: Unknown
SHMZF OTC Market Information
Shimadzu Corporation trades on the OTC (Over-The-Counter) market under the 'OTC Other' tier. This tier typically includes companies that do not meet the listing requirements for OTCQX or OTCQB, or choose not to apply for them. Unlike major exchanges like NYSE or NASDAQ, which have stringent listing standards regarding financial health, corporate governance, and share price, OTC markets have varying levels of disclosure and liquidity. 'OTC Other' generally implies a lower level of public disclosure compared to higher OTC tiers, which can impact investor access to comprehensive financial information and overall market transparency.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Lower liquidity and wider bid-ask spreads compared to exchange-listed stocks, potentially impacting trade execution.
- Limited public disclosure of financial and operational information due to the 'Unknown' disclosure status, increasing information asymmetry.
- Increased susceptibility to market manipulation due to less regulatory oversight and lower trading volumes.
- Difficulty in obtaining reliable price quotes and market data, hindering accurate valuation and investment decisions.
- Potential for delisting or further tier downgrades if disclosure or financial standards are not met, impacting investor confidence.
- Verify the company's latest available financial statements and annual reports directly from official sources, if any.
- Research any news or press releases from the company to understand recent developments and strategic initiatives.
- Examine the company's corporate governance structure and management team beyond the provided CEO name.
- Assess the trading volume and bid-ask spread over a period to understand the stock's liquidity characteristics.
- Investigate any regulatory filings or compliance records available for the company in its home country.
- Evaluate the company's business model and competitive landscape thoroughly, given potentially limited public data.
- Consult with a financial advisor experienced in OTC markets to understand specific risks and opportunities.
- Long operating history since 1875, indicating a well-established business.
- Global presence and diversified product lines across multiple high-tech sectors.
- Substantial employee count of 14,519, suggesting a significant operational scale.
- Headquartered in Kyoto, Japan, a developed economy with established corporate governance norms.
- Publicly available financial metrics like Market Cap, P/E, and margins, despite OTC listing.
Common Questions About SHMZF (Technology)
What does Shimadzu Corporation do?
Shimadzu Corporation is a diversified global technology company that manufactures and sells a wide array of high-precision products. Its core business segments include analytical and measuring instruments, which are critical for scientific research and quality control across industries like pharmaceuticals and environmental monitoring. Additionally, it provides advanced medical systems such as angiography and X-ray units for diagnostics. The company also produces industrial machinery, including vacuum pumps and heat-treatment furnaces, and supplies specialized aircraft equipment like flight control systems. Founded in 1875, Shimadzu leverages its deep engineering expertise to serve a worldwide customer base with innovative solutions across these technology-intensive sectors.
How does Shimadzu Corporation invest in research and development?
Shimadzu Corporation's long history of innovation underscores its commitment to research and development, which is crucial for maintaining its competitive edge in technology-driven markets. While specific R&D spending as a percentage of revenue is not provided, the company's extensive and diverse product portfolio across analytical instruments, medical systems, industrial machinery, and aircraft equipment indicates significant ongoing investment. Key innovation areas likely include enhancing the precision and capabilities of its chromatography and mass spectrometry systems, developing next-generation medical imaging technologies, and advancing materials science for industrial and aerospace applications. This continuous R&D effort is essential for introducing new products, improving existing ones, and securing patents to protect its intellectual property.
What are the main risks for SHMZF?
Shimadzu Corporation faces several key risks inherent to its diverse operations and global presence. Ongoing intense global competition across its analytical, medical, industrial, and aerospace segments could pressure market share and pricing power. The company is also exposed to potential fluctuations in global economic conditions, which could reduce capital expenditure from its industrial and healthcare clients, impacting demand for its high-value equipment. Furthermore, the rapid pace of technological advancements necessitates continuous and substantial R&D investment to prevent product obsolescence. Supply chain disruptions or increases in raw material costs represent potential threats to production efficiency and profitability. Lastly, regulatory changes in the various sectors it serves could impose new compliance burdens or restrict market access.
How exposed is Shimadzu Corporation to technology disruption risks?
Shimadzu Corporation, operating in multiple high-technology sectors, faces inherent exposure to technology disruption risks. The company's diverse portfolio, while a strength, also means it must monitor emerging technologies across analytical science, medical diagnostics, industrial automation, and aerospace engineering. Rapid advancements in areas like AI-driven analytics, new imaging modalities, advanced manufacturing techniques, or novel materials could potentially render existing products less competitive if not addressed through continuous innovation. Shimadzu mitigates this by investing heavily in R&D, aiming to be a disruptor rather than disrupted. However, the pace of technological change and the emergence of agile competitors remain an ongoing challenge, requiring constant adaptation and strategic foresight to maintain market relevance.
What are the key factors to evaluate for SHMZF?
Shimadzu Corporation (SHMZF) holds an AI score of 51/100 (moderate). P/E: 19.7x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does SHMZF data refresh on this page?
SHMZF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven SHMZF's recent stock price performance?
Shimadzu Corporation (SHMZF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Highly diversified product portfolio across analytical, medical, industrial, and aerospace sectors. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider SHMZF overvalued or undervalued right now?
Shimadzu Corporation (SHMZF) trades at 19.7x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- CEO background and track record details were not provided in the source data, hence marked as 'Unknown'.